Skip to content Skip to footer

As Monsanto Pays $289 Million to Cancer Victim, Bayer Shares Plunge

At one point the German pharmaceutical giant’s shares fell by as much as 14 percent.

Dewayne Johnson (C) hugs one of his attorneys, next to lawyer and member of his legal team Robert F Kennedy Jr (R), after the verdict was read in the case against Monsanto at the Superior Court Of California in San Francisco, California, on August 10, 2018.

Shares in Bayer took a nosedive on Monday — just days after newly-acquired Monsanto was ordered to pay $289 million in damages to a man who alleged that the company’s glyphosate-based herbicides, including the widely used weedkiller Roundup, caused his cancer.

At one point the German pharmaceutical giant’s shares fell by as much as 14 percent, Reuters reported, marking a loss in value of roughly $14 billion.

It capped off the US trading day as one of the “biggest losers,” ending at a 10-percent loss.

Friday was also a losing day for Monsanto, which Bayer AG controversially acquired for $62.5 billion in June. In a landmark trial, a San Francisco jury unanimously found that the company failed to warn school groundskeeper Dewayne Johnson, who’s suffering from non-Hodgkin’s lymphoma, and other consumers of the cancer risks from its weed killers, and said the company acted “with malice or oppression.”

The International Agency for Research on Cancer (IARC) — a branch of the World Health Organization (WHO) — classified glyphosate as a probable human carcinogen, but Monsanto says its Roundup is safe, and that it plans on appealing.

Monday also marked the last day of the public comment period for the finalization of the merger process, prompting a broad range of advocacy groups to voice their opposition once again.

“No matter how you cut it,” said said Daniel Raichel, an attorney with the Nature Program at NRDC, “a Bayer/Monsanto merger spells higher costs for farmers and locks in the chemical-heavy agricultural practices that threaten our health and the bees and other pollinators critical to food security.”

“The Department needs to reverse course and block the merger before we all suffer the consequences,” he said.

Briefly, we wanted to update you on where Truthout stands this month.

To be brutally honest, Truthout is behind on our fundraising goals for the year. There are a lot of reasons why. We’re dealing with broad trends in our industry, trends that have led publications like Vice, BuzzFeed, and National Geographic to make painful cuts. Everyone is feeling the squeeze of inflation. And despite its lasting importance, news readership is declining.

To ensure we stay out of the red by the end of the year, we have a long way to go. Our future is threatened.

We’ve stayed online over two decades thanks to the support of our readers. Because you believe in the power of our work, share our transformative stories, and give to keep us going strong, we know we can make it through this tough moment.

We’ve launched a campaign to raise $42,000 in the next 6 days. Please consider making a donation today.